ANGELIQ

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Netherlands, Poland, Turkey, United States

Active ingredients

The drug ANGELIQ contains a combination of these active pharmaceutical ingredients (APIs):

1 Estradiol UNII CXY7B3Q98Z - ESTRADIOL HEMIHYDRATE

Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy. Read about Estradiol

2 Drospirenone UNII N295J34A25 - DROSPIRENONE

Drospirenone is a progestogen. In a therapeutic dosage, drospirenone also possesses antiandrogenic and mild antimineralocorticoid properties. It has no estrogenic, glucocorticoid and antiglucocorticoid activity. This gives drospirenone a pharmacological profile closely resembling the natural hormone progesterone. Read about Drospirenone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03FA17	Drospirenone and estrogen	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03F Progestogens and estrogens in combination → G03FA Progestogens and estrogens, fixed combinations
Discover more medicines within G03FA17

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 538901901112314
Country: CA	Health Products and Food Branch	Identifier(s): 02268825
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01689021
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 26.136-01-05
Country: EE	Ravimiamet	Identifier(s): 1165711, 1165722
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 65583
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 015089
Country: FR	Base de données publique des médicaments	Identifier(s): 67172690
Country: HK	Department of Health Drug Office	Identifier(s): 53676
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-410626445
Country: IE	Health Products Regulatory Authority	Identifier(s): 12463
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4865
Country: IT	Agenzia del Farmaco	Identifier(s): 036170013
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1017736, 1017737, 1085696, 1087563
Country: MT	Medicines Authority	Identifier(s): MA639/01501
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 003M2005
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 117226
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100137084
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699546097494
Country: US	FDA, National Drug Code	Identifier(s): 50419-482, 50419-483